JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
80 hedge funds and large institutions have $122M invested in Jounce Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 5 closing their positions.
Holders
80
Holders Change
–
Holders Change %
0%
% of All Funds
1.74%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
7
Increased
27
Reduced
31
Closed
5
Calls
$161K
Puts
$58K
Net Calls
+$103K
Net Calls Change
-$68K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$3.96M |
| 2 |
2
Nuveen Asset Management
Chicago,
Illinois
|
$693K |
| 3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$3.85M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$1.85M |
| 5 |
SO
5
STRS Ohio
Columbus,
Ohio
|
$470K |
